Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GSEV
2101
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
| $14.9M | ﹤0.01% |
1,519,369
+549
| +0% | +$5.38K |
|
2102
First Trust Senior Loan Fund ETF
FTSL
$2.33B
| $14.8M | ﹤0.01% |
336,670
+238,745
| +244% | +$11M |
|
2103
EPR Properties
EPR
$4.69B
| $14.8M | ﹤0.01% |
315,461
+112,519
| +55% | +$5.7M |
|
|
NVMI
2104
CALL
Nova
NVMI
$13.3B
| $14.8M | ﹤0.01% |
167,200
+146,400
| +704% | +$14.6M |
|
2105
Packaging Corp of America
PKG
$22.8B
| $14.8M | ﹤0.01% |
107,625
+76,698
| +248% | +$11.9M |
|
2106
CALL
Elastic
ESTC
$9.01B
| $14.8M | ﹤0.01% |
218,600
-255,600
| -54% | -$18.6M |
|
2107
ARK Genomic Revolution ETF
ARKG
$1.74B
| $14.8M | ﹤0.01% |
469,505
+436,404
| +1,318% | +$15.3M |
|
2108
PUT
ProShares Ultra Bloomberg Crude Oil
UCO
$430M
| $14.8M | ﹤0.01% |
352,700
-222,900
| -39% | -$9.85M |
|
2109
CALL
ArcelorMittal
MT
$55.7B
| $14.8M | ﹤0.01% |
653,100
+182,900
| +39% | +$5.36M |
|
2110
Everest Group
EG
$14.2B
| $14.8M | ﹤0.01% |
52,652
+47,759
| +976% | +$13.5M |
|
2111
Lamb Weston
LW
$7.3B
| $14.8M | ﹤0.01% |
206,444
-514,018
| -71% | -$34M |
|
2112
Murphy Oil
MUR
$4.96B
| $14.7M | ﹤0.01% |
488,521
+444,585
| +1,012% | +$17.1M |
|
2113
ExxonMobil
XOM
$658B
| $14.7M | ﹤0.01% |
172,057
-1,075,482
| -86% | -$97M |
|
2114
PUT
Tenet Healthcare
THC
$21.6B
| $14.7M | ﹤0.01% |
280,200
-30,200
| -10% | -$2.1M |
|
|
EXEEL
2115
DELISTED
Expand Energy Corp Class C Warrants
EXEEL
| $14.7M | ﹤0.01% |
280,441
+47,460
| +20% | +$2.89M |
|
|
ITOS
2116
DELISTED
iTeos Therapeutics
ITOS
| $14.7M | ﹤0.01% |
713,712
+192,241
| +37% | +$4.56M |
|
2117
SoFi Technologies
SOFI
$23.6B
| $14.7M | ﹤0.01% |
2,786,005
+1,187,076
| +74% | +$8.02M |
|
2118
CALL
Dave & Buster's
PLAY
$354M
| $14.7M | ﹤0.01% |
447,800
-5,100
| -1% | -$205K |
|
2119
Cloudflare
NET
$112B
| $14.7M | ﹤0.01% |
335,397
-43,022
| -11% | -$3.1M |
|
2120
PUT
International Paper
IP
$21.6B
| $14.7M | ﹤0.01% |
350,600
-72,500
| -17% | -$3.36M |
|
2121
Starwood Property Trust
STWD
$6.03B
| $14.7M | ﹤0.01% |
702,068
+39,444
| +6% | +$907K |
|
|
JKS
2122
CALL
JinkoSolar
JKS
$877M
| $14.7M | ﹤0.01% |
211,900
-73,900
| -26% | -$4.14M |
|
2123
PUT
XPO
XPO
$24.7B
| $14.6M | ﹤0.01% |
511,464
+265,241
| +108% | +$8.44M |
|
2124
Star Bulk Carriers
SBLK
$3.24B
| $14.6M | ﹤0.01% |
585,497
+386,835
| +195% | +$11.2M |
|
|
GAP
2125
PUT
The Gap Inc
GAP
$7.42B
| $14.6M | ﹤0.01% |
1,775,500
+18,200
| +1% | +$211K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.